Literature DB >> 2176296

Clinical subtypes of unipolar depression: Part III. Quantitative differences in various biological markers between the cluster-analytically generated nonvital and vital depression classes.

M Maes1, L Maes, C Schotte, M Vandewoude, M Martin, P D'Hondt, P Blockx, S Scharpé, P Cosyns.   

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis, the hypothalamic-pituitary-thyroid (HPT) axis, and the availability of L-tryptophan (L-TRP) to the brain were studied in their relationships to (1) 14 depressive symptoms measured by the Structured Clinical Interview for DSM-III-R--Patient Version (SCID) and (2) the cluster-analytically generated vital/nonvital classes. The following biological parameters were measured in 100 depressed females: free thyroxine (FT4), baseline thyroid stimulating hormone (TSH), predexamethasone and postdexamethasone cortisol and adrenocorticotropic hormone (ACTH) values, the circulating levels of total L-TRP, and the L-TRP/sum of competing amino acids ratio. We found that the psychopathological correlates of disorders in the HPA/HPT axis and of a decreased availability of L-TRP were vital symptoms, i.e., distinct quality of mood, nonreactivity, early morning awakening, anorexia-weight loss, and psychomotor disorders. There was no significant relationship between those biological markers and the nonvital symptoms of the SCID inventory for depressive symptoms. However, we did not validate our SCID clustering in vital and nonvital classes by qualitative differences in the biological variables. It was concluded that our nonvital/vital clusters should be regarded as continuous categories with regard to the biological markers studied; these clusters constitute relevant stages in the continuum of progressing biological dysfunction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176296     DOI: 10.1016/0165-1781(90)90058-d

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  BDNF Val66Met polymorphism and stressful life events in melancholic childhood-onset depression.

Authors:  Timea Rimay; Istvan Benak; Eniko Kiss; Ildiko Baji; Agnes Feher; Anna Juhasz; John Strauss; James Kennedy; Cathy Barr; Maria Kovacs; Agnes Vetro; Krisztina Kapornai
Journal:  Psychiatr Genet       Date:  2015-12       Impact factor: 2.458

2.  Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning.

Authors:  Buranee Kanchanatawan; Sira Sriswasdi; Supaksorn Thika; Sunee Sirivichayakul; André F Carvalho; Michel Geffard; Marta Kubera; Michael Maes
Journal:  Metab Brain Dis       Date:  2018-03-11       Impact factor: 3.584

3.  Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Supaksorn Thika; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Cristiano Noto; Rada Ivanova; Michael Maes
Journal:  Metab Brain Dis       Date:  2017-03-03       Impact factor: 3.584

Review 4.  Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.

Authors:  Michael Maes; Michael Berk; Lisa Goehler; Cai Song; George Anderson; Piotr Gałecki; Brian Leonard
Journal:  BMC Med       Date:  2012-06-29       Impact factor: 8.775

5.  Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self.

Authors:  Michael Maes
Journal:  J Pers Med       Date:  2022-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.